Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HR 475Session 2025-2026

A Resolution recognizing the month of September 2026 as "ITP Awareness Month" in Pennsylvania.

Printer's No. PN3258

See other bills
under the
same topic PRINTER'S NO. 3258 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.475 Session of 2026 INTRODUCED BY RIVERA, FREEMAN, GUZMAN, VENKAT, SANCHEZ, HILL-EVANS, CEPEDA-FREYTIZ, HOHENSTEIN, NEILSON AND PASHINSKI, APRIL 22, 2026 REFERRED TO COMMITTEE ON HEALTH, APRIL 22, 2026 A RESOLUTIONRecognizing the month of September 2026 as "ITP Awareness Month" in Pennsylvania.WHEREAS, Immune thrombocytopenia, otherwise known as ITP, is a rare autoimmune disease that causes an individual to have a low platelet count, which may cause bruising, bleeding and fatigue; andWHEREAS, In severe cases, individuals can experience brain bleeds or bleeding from their mouth, nose and gums; andWHEREAS, The Platelet Disorder Support Association observes September as "ITP Awareness Month" annually to raise awareness, enhance research and develop better outcomes for individuals living with ITP; andWHEREAS, Diagnosing ITP is difficult because there is not a specific test to identify it or a specific cause for how it develops; andWHEREAS, Diagnosis may include a physical examination, blood smears, bone marrow examination or other blood tests; and1234567891011121314151617 WHEREAS, The three phases of ITP are newly diagnosed ITP, persistent ITP and chronic ITP, each with numerous symptoms and side effects and classified by the length of time a person has had the condition; andWHEREAS, Unlike other diseases there is no estimated timeline for how long ITP will last, as the condition can be chronic and last for more than a year or be persistent and last about six to 12 months; andWHEREAS, Standard treatment consists of undergoing blood and platelet transfusions and plasma exchanges and managing ITP caused by some viral, bacterial and other infections; andWHEREAS, A splenectomy may also be necessary to remove the spleen in order to prevent platelets from being circulated and potentially destroyed by antibodies; andWHEREAS, Recovery from ITP varies depending on the individual, and there is no cure or treatment that is guaranteed to be effective; andWHEREAS, Patients often have to undergo different treatments and medications to determine which is most effective for their condition; andWHEREAS, While children are more likely to recover from ITP without treatment, adults tend to recover at slower rates and may require treatment for the rest of their lives; andWHEREAS, Patients with ITP may need to avoid participating in contact sports and other activities due to potential injuries and avoid taking certain medications because of the high risk of internal bleeding; andWHEREAS, More than 50,000 people in the United States are surviving and managing their ITP; andWHEREAS, While ITP can affect anyone of any age, studies have 20260HR0475PN3258 - 2 - 123456789101112131415161718192021222324252627282930 shown that women 30 to 60 years of age are more likely to have ITP; andWHEREAS, It is crucial to spread awareness for rare autoimmune diseases such as ITP to encourage research studies to be conducted, discovery of more effective treatments and potential cures and to support those who are impacted by the conditions; therefore be itRESOLVED, That the House of Representatives recognize the month of September 2026 as "ITP Awareness Month" in Pennsylvania.20260HR0475PN3258 - 3 - 12345678910

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.